More Investing
View Older Stories View Newer Stories-
Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace
-
SoFi launches Options Level 1 for members with commission-free trading
-
Nike upgraded by KeyBanc as turnaround gains traction after Q1 beat
-
Apple hardware ecosystem safe from AI smart glasses for next 2-3 years: analyst
-
Chip stocks rise as OpenAI’s Stargate project fuels AI memory demand hype
-
SaaS stock selloff overdone, says BofA
-
Eric Trump reportedly opens Citi account, deposits some of father’s trust money
-
Occidental climbs after selling chemical business to Buffett's Berkshire
-
Bessent expects ’big breakthrough’ in next China trade talks
-
Is there risk of a momentum unwind? Bernstein answers
-
Citi lifts Bitcoin, Ethereum price forecasts. Here are the new targets
-
Stellantis stock jumps as Morgan Stanley says share gains are finally taking place
-
Apple target lifted at Morgan Stanley on stronger-than-expected iPhone 17 cycle
-
Thales jumps as Kepler ups shares to Buy on attractive valuation
-
Exclusive: FG Nexus to tokenize public shares on Ethereum in deal with Securitize
-
HSBC lifts Ferrari to Buy on strong growth outlook through 2030, shares climb
-
Credit bureaus fall sharply as FICO launches direct-to-lender score program
-
Raytheon secures $77.8 million in defense contracts
-
Lockheed Martin secures over $1.4 billion in defense contracts
-
GoodRx stock soars after CEO hints at potential TrumpRx partnership
-
Private jobs sink in September, but Morgan Stanley wary of bets on jumbo rate cut
-
Intel spikes on reports of potential AMD manufacturing deal
-
Autodesk ’well-placed to monetize AI’ says HSBC
-
Raymond James upgrades SkyWest on demand recovery and valuation
-
Reddit stock tumbles on concerns over declining user engagement
-
Barclays downgrades Viasat as satellite supply surges
-
Supreme Court allows Fed's Cook to remain in post during legal battle
-
Evercore ISI upgrades Samsara sees ‘lots of open road ahead’
-
Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper
-
GE Vernova's strong outlook already priced in, RBC says as it downgrades stock
-
Canada’s manufacturing PMI signals prolonged slump in output and orders
-
Barclays downgrades AT&T as valuation reflects operational gains
-
TD Cowen downgrades Marvell on weaker visibility in custom chip business
-
William Blair: 'Increasingly difficult' to like Tesla stock amid rich valuation
-
Carvana upgraded by Jefferies on signs of faster market share gains
-
Here are the October additions to Goldman's 'U.S. Conviction List - Directors' Cut
-
ADP reports biggest private payroll drop in 2.5 years, fueling Fed cut bets
-
Is the U.S. drug pricing deal good for Pfizer?
-
Peloton shares jump after AI-driven overhaul
-
Netflix stock falls after Elon Musk urges followers to cancel service
-
BofA's Sell Side Indicator stays neutral as S&P 500 around record highs
-
Wells Fargo launches software coverage, highlights AI shift as inflection point
-
Jefferies bullish on United Airlines, sees revenue momentum and margin potential
-
Lockheed Martin secures $1.47 billion in defense contracts
-
Marvell Technology stock falls after TD Cowen downgrade on cloud visibility
-
Defensive stocks show deep value as cyclicals run hot, UBS says
-
Social media stocks slide as OpenAI launches Sora 2 model and video generation app
-
"We’ll probably have a shutdown," says Trump
-
US trade chief Greer calls 55% China tariffs a "good status quo"
-
Maersk stock target cut at UBS on overcapacity headwinds
